Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 30 citing articles:

Correlation of gut microbiota and metabolic functions with the antibody response to the BBIBP-CorV vaccine
Bo Tang, Li Tang, Wei He, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100752-100752
Open Access | Times Cited: 31
Immunoglobulins response of COVID-19 patients, COVID-19 vaccine recipients, and random individuals
Mohammad Al‐Tamimi, Amjed A. Tarifi, Arwa Qaqish, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281689-e0281689
Open Access | Times Cited: 17
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies
Lucia Spicuzza, Davide Campagna, Chiara Di Maria, et al.
AIMS Microbiology (2023) Vol. 9, Iss. 2, pp. 375-401
Open Access | Times Cited: 14
Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes
Rhiane Moody, Sabrina Sonda, Fay H. Johnston, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection
Kimia Sobhani, Susan Cheng, Raquel A. Binder, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1644-1644
Open Access | Times Cited: 13
The Levels of Anti-SARS-CoV-2 Spike Protein IgG Antibodies Before and After the Third Dose of Vaccination Against COVID-19
Małgorzata Łysek-Gładysińska, Magdalena Starz, Agnieszka Borowiec-Sęk, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 145-160
Open Access | Times Cited: 11
Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital
Vidya Arankalle, A. G. Kulkarni, Ruta Kulkarni, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Dynamic Changes and Trends of SARS‐CoV‐2 Antibodies Induced by Infection and Vaccination Across Multiple Time Points
S.P. Zhang, Xiaoxiao Kong, Qian Zhen, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Open Access
Kinetics of SARS-CoV-2 Serum Antibodies Through the Alpha, Delta, and Omicron Surges Among Vaccinated Health Care Workers at a Boston Hospital
Maura C Dodge, Lei Ye, Elizabeth R. Duffy, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 7
Open Access | Times Cited: 8
SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants
Junxiang Wang, Kaiyi Li, Xinyue Mei, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 12
The RdRp genotyping of SARS-CoV-2 isolated from patients with different clinical spectrum of COVID-19
Michał Majchrzak, Łukasz Madej, Małgorzata Łysek-Gładysińska, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Applications of SARS-CoV-2 serological testing: impact of test performance, sample matrices, and patient characteristics
Chun Yiu Jordan Fung, Mackenzie Scott, Jordan Lerner‐Ellis, et al.
Critical Reviews in Clinical Laboratory Sciences (2023) Vol. 61, Iss. 1, pp. 70-88
Closed Access | Times Cited: 4
SARS-CoV-2 Antibody Kinetics in Unvaccinated Hospitalized Children With COVID-19
Dimitra Dimopoulou, Marietta Charakida, Antonios Marmarinos, et al.
The Pediatric Infectious Disease Journal (2024) Vol. 43, Iss. 6, pp. 536-542
Closed Access | Times Cited: 1
High SARS-CoV-2 infection rate in children unvaccinated with COVID-19 vaccine in Changzhou, China, shortly after lifting zero-COVID-19 policy in December 2022
Jie Tang, Yong Wang, Weiqin Lu, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Neutralizing Antibody-Mediated Protection from Prior Delta Variant Infection Against Omicron BA.5 Sub-Lineage Reinfection One Year Later: A Prospective Cohort Study
Shihan Zhang, Yin Wang, Xu Guo, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1211-1211
Open Access | Times Cited: 1
Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects
Latha Dulipsingh, Ernst J. Schaefer, Dorothy Wakefield, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e17410-e17410
Open Access | Times Cited: 3
Evaluation of Antibody Response and Adverse Effects following Heterologous COVID-19 Vaccine Booster with mRNA Vaccine among Healthcare Workers in Indonesia
Gatot Soegiarto, Bagus Aulia Mahdi, Laksmi Wulandari, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1160-1160
Open Access | Times Cited: 3
Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina
Pamela Elizabeth Rodríguez, Andrea P. Silva, Esteban A. Miglietta, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
The Comparative Superiority of SARS-CoV-2 Antibody Response in Different Immunization Scenarios
Ourania S. Kotsiou, Nikolaos D. Karakousis, Dimitrios Papagiannis, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1756-1756
Open Access | Times Cited: 4
Temporal trends of COVID-19 antibodies in vaccinated healthcare workers undergoing repeated serological sampling: An individual-level analysis within 13 months in the ORCHESTRA cohort
Giulia Collatuzzo, Giuseppe De Palma, Francesco Saverio Violante, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 2
Unveiling a New Perspective on Distinguishing Omicron Breakthrough Cases and Postimmune COVID-19-Naive Individuals: Insights from Antibody Profiles
Shihan Zhang, Dong Chen, Qian Zhen, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 2
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
Helen Ratcliffe, Karen S. Tiley, Stephanie Longet, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108500-108500
Open Access | Times Cited: 2
Long follow-up of BNT162b2 mRNA vaccine in healthcare workers (2020–2022): A retrospective longitudinal SARS-CoV-2 serological surveillance
Vanessa De Pace, Bianca Bruzzone, Valentina Ricucci, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 1
Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell cluster
Stine Sofie Frank Lende, Nanna Moeller Barnkob, Randi Westh Hansen, et al.
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0291131-e0291131
Open Access | Times Cited: 1
Severe Avian Influenza A H5N1 Clade 2.3.4.4b Virus Infection in a Human with Continuation of SARS-CoV-2 Viral RNAs
Huiyan Yu, Ke Jin, Songning Ding, et al.
Transboundary and Emerging Diseases (2024) Vol. 2024, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top